Happy to see this paper out and grateful for the opportunity to contribute to this very nice work! Congratulations TiberiLab Chiara Lago!!

Finding new treatments for medulloblastoma is the aim of a group of international researchers who are joining forces. In the lab they will, among other things, mimic tumor development in the brain. research.prinsesmaximacentrum.nl/en/news-events… Research@TheBrainTumourCharity

Prof. dr. Marcel Kool has been appointed professor of Childhood brain tumors at UMC Utrecht International. 'There are many different kinds of brain tumors in children. The big challenge is to find effective treatments for all these types of tumors.' ➡ research.prinsesmaximacentrum.nl/en/news-events…

Recently established non-profit company ITCC-P4 gGmbH is the first worldwide to provide academic institutions & pharmaceutical companies with comprehensive repertoire of modern lab models to promote preclinical drug testing for children with cancer. 👏

bit.ly/3o9NJ0X

The moment Napoli conquered Italy 🥺

(via tntsportsfootball)

I couldn't be happier!!!

Excited to be in beautiful and sunny Orlando, Florida for #AACR23 ! Can't wait to dive into all the inspiring talks and posters. Stop by my poster (3571) on Tuesday morning to learn more about our #ITCCP4 PDX work! #CancerResearch #PediatricCancer

Come work in my group! I have two positions open for motivated bioinformatically skilled postdocs. Hopp-Kindertumorzentrum Heidelberg (KiTZ) DKFZ #hiring #translationalgenomics

jobs.dkfz.de/en/jobs/145306…

Glad to report that our latest study is out in Acta Neuropathologica Communications! Analysis of gene expression profiles in medulloblastoma relapse tumors opens new interesting perspectives,thanks a lot to all the authors, check the paper here: actaneurocomms.biomedcentral.com/articles/10.11…

Being an academic mostly involves saying “it will all calm down next week and I’ll get some proper work done”.

My new R package ( #SCpubr ) based on #Seurat (Rahul Satija) for generating high quality, publication-ready plots for #SingleCellRNASeq is finally on #CRAN !

Check it out!
enblacar.github.io/SCpubr-book/

#rstats #ggplot2 #DataViz #bioinformatics

Scientists from the Máxima, Hopp-Kindertumorzentrum Heidelberg (KiTZ), DKFZ and Universitätsklinikum Heidelberg have come together this week to exchange ideas and make plans for their joint 'Twinning Program'. Read more about one year of collaborating with these leading German centers: bit.ly/newperspective… #newperspectives

Very excited to attend the next general meeting of #ittcp4 next week! After the pandemic, it is finally the first occasion to meet many colleagues across Europe working on our common project: to establish a platform of patient-derived models of high-risk #pediatric malignancies.

Our new study is out on #ActaNeuropathologica ! We showed a novel stratification of #ATRT SHH patients into 3 subgroups with distinct molecular and clinical features. Thanks to all the co-authors, especially to Martin and @ccthomas10! Uniklinik Münster Hopp-Kindertumorzentrum Heidelberg (KiTZ)
link.springer.com/article/10.100…

Konstantin Olmezov R.I.P.
(1995-March 20, 2022)
Konstantin was from Ukraine, he studied in Donetsk National University. He left Donetsk because of the war and eventually began graduate studies in mathematics in MIPT, Russia.

I can totally relate to that!

Great studies from great colleagues! Konstantin Okonechnikov Lena Kutscher Hopp-Kindertumorzentrum Heidelberg (KiTZ) Neurooncology_HD Will sure be amongst my top Christmas reads this year!

my #singlecell #UMAP projection today looked like a fantasy animation!

I am very honored and grateful that the Arnfried and Hannelore Meyer Foundation chose to support our joint Hopp-Kindertumorzentrum Heidelberg (KiTZ)- PrinsesMáximaCentrum project. Every contribution is essential to pursue our aim: finding effective therapeutic options targeting the #brainTME in pediatric cancer!

The research fund established by the KiTZ and the Princess Máxima Center is intended to boost European pediatric oncology #research – to develop therapies with fewer side effects that are specifically tailored to children. 🧬🔬🙌